On 7 June_, the FDA approved aducanumab, the first new drug for Alzheimer’s disease in almost 20 years—and notably, the first drug with a putative disease-modifying mechanism for the treatment of this devastating disorder, namely the removal of β-amyloid (or Aβ) plaques from the brain.

中文翻译：

---

Aducanumab：阿尔茨海默病治疗开发的新阶段？

6 月 7 日_， FDA 批准了 aducanumab，这是近 20 年来第一个治疗阿尔茨海默病的新药，值得注意的是，这是第一个具有假定的疾病缓解机制的药物，用于治疗这种破坏性疾病，即去除 β-淀粉样蛋白。或 Aβ）来自大脑的斑块。